Hyperaldosteronism Overview
Learn About Hyperaldosteronism
Hyperaldosteronism is a condition in which the adrenal gland releases too much of the hormone aldosterone into the blood.
Hyperaldosteronism can be primary or secondary.
Conn syndrome; Mineralocorticoid excess
Hyperaldosteronism occurs when the adrenal glands release too much aldosterone.
Primary hyperaldosteronism is due to a problem of the adrenal glands themselves. Most cases are caused by a noncancerous (benign) tumor of the adrenal gland.
Secondary hyperaldosteronism is due to a problem elsewhere in the body that causes the adrenal glands to release too much aldosterone. These problems can be with:
- Genes
- Diet
- Medical disorders such as with the heart, liver, kidneys, or high blood pressure
The condition mostly affects people 30 to 50 years old and is a common cause of high blood pressure in middle age.
Primary and secondary hyperaldosteronism have common symptoms, including:
- High blood pressure
- Low level of potassium in the blood
- Feeling tired all the time
- Headache
- Muscle weakness
- Numbness
Primary hyperaldosteronism caused by an adrenal gland tumor is often treated with surgery. It can sometimes be treated with medicines.
Removing the adrenal tumor may control the symptoms. Even after surgery, some people still have high blood pressure and need to take medicine for it. But often, the number of medicines or doses can be lowered.
Limiting salt intake and taking medicine may control the symptoms without surgery. Medicines to treat hyperaldosteronism include:
- Medicines that block the action of aldosterone
- Water pills (diuretics), which help manage fluid buildup in the body
Secondary hyperaldosteronism is treated with medicines (as described above) and limiting salt intake. Surgery is usually not used.
Penn Endocrine And Oncologic Surgery Radnor
Heather Wachtel is a General Surgeon in Radnor, Pennsylvania. Dr. Wachtel has been practicing medicine for over 17 years and is rated as an Elite provider by MediFind in the treatment of Hyperaldosteronism. Her top areas of expertise are Hyperaldosteronism, Hyperparathyroidism, Pheochromocytoma, Parathyroidectomy, and Thyroidectomy. Dr. Wachtel is currently accepting new patients.
Martin Reincke practices in Augsburg, Germany. Mr. Reincke is rated as an Elite expert by MediFind in the treatment of Hyperaldosteronism. His top areas of expertise are Hyperaldosteronism, Cushing's syndrome, Adrenal Gland Adenoma, Cushing's disease, and Hormone Replacement Therapy (HRT).
Gian Rossi practices in Padova, Italy. Mr. Rossi is rated as an Elite expert by MediFind in the treatment of Hyperaldosteronism. His top areas of expertise are Hyperaldosteronism, Hypertension, Adrenal Cancer, Angioplasty, and Endoscopy.
The outlook for primary hyperaldosteronism is good with early diagnosis and treatment.
The outlook for secondary hyperaldosteronism depends on the cause of the condition.
Primary hyperaldosteronism can cause very high blood pressure, which can damage many organs, including the eyes, kidneys, heart, and brain.
Erection problems and enlarged breast tissue in men (gynecomastia) may occur with long-term use of medicines to block the effect of hyperaldosteronism.
Contact your provider if you develop symptoms of hyperaldosteronism.
Background: Alcohol use disorder (AUD) affects about 29.5 million people in the United States. Only 3 medicines have been approved by Food and Drug Administration to treat AUD. Researchers want to find better treatments for AUD. Animal studies found that a medicine called spironolactone, may decrease the amount of alcohol the animals drank. Spironolactone is approved to treat high blood pressure, or heart fai...
Summary: The study aims to assess the effect of superselective adrenal arterial embolization on vascular endothelial function in patients with primary aldosteronism based on brachial artery flow-mediated relaxation
Published Date: July 13, 2025
Published By: Sandeep K. Dhaliwal, MD, board-certified in Diabetes, Endocrinology, and Metabolism, Springfield, VA. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.
Guber HA, Oprea M, Russell YX. Evaluation of endocrine function. In: McPherson RA, Pincus MR, eds. Henry's Clinical Diagnosis and Management by Laboratory Methods. 24th ed. Philadelphia, PA: Elsevier; 2022:chap 25.
Nieman LK. Adrenal cortex. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 208.
Weiner ID, Wingo CS. Endocrine causes of hypertension: aldosterone. In: Johnson RJ, Floege J, Tonelli M, eds. Comprehensive Clinical Nephrology. 7th ed. Philadelphia, PA: Elsevier; 2024:chap 39.
Young WF. Endocrine hypertension. In. Melmed S, Auchus RJ, Goldfine AB, Rosen CJ, Kopp PA, eds. Williams Textbook of Endocrinology. 15th ed. Philadelphia, PA: Elsevier; 2025:chap 14.